BioAdvance — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Tolerance Biotolerancebio.comJun 2026
BiotechPhiladelphia, US
Philip Ball(Executive Officer, Director)Damia Tormo Carulla(Director)Justin Vogel(Executive Officer, Director)Francisco Leon(Executive Officer, Director)Robert Goldstein(Director)
BoardPablo Cironi(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.